These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 35843187

  • 1. Luteolin ameliorates hypoxia-induced pulmonary hypertension via regulating HIF-2α-Arg-NO axis and PI3K-AKT-eNOS-NO signaling pathway.
    Ji L, Su S, Xin M, Zhang Z, Nan X, Li Z, Lu D.
    Phytomedicine; 2022 Sep; 104():154329. PubMed ID: 35843187
    [Abstract] [Full Text] [Related]

  • 2. Tsantan Sumtang, a traditional Tibetan medicine, protects pulmonary vascular endothelial function of hypoxia-induced pulmonary hypertension rats through AKT/eNOS signaling pathway.
    Li N, Su S, Xie X, Yang Z, Li Z, Lu D.
    J Ethnopharmacol; 2024 Feb 10; 320():117436. PubMed ID: 37979813
    [Abstract] [Full Text] [Related]

  • 3. 4-Terpineol attenuates pulmonary vascular remodeling via suppressing PI3K/Akt signaling pathway in hypoxia-induced pulmonary hypertension rats.
    Gu C, Yang Z, Su S, Ma K, Nan X, Li Z, Lu D.
    Toxicol Appl Pharmacol; 2023 Aug 15; 473():116596. PubMed ID: 37328117
    [Abstract] [Full Text] [Related]

  • 4. Luteolin ameliorates hypoxic pulmonary vascular remodeling in rat via upregulating KV1.5 of pulmonary artery smooth muscle cells.
    Zhang Z, Chen J, Su S, Xie X, Ji L, Li Z, Lu D.
    Phytomedicine; 2024 Sep 15; 132():155840. PubMed ID: 38941817
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Kaempferol ameliorates pulmonary vascular remodeling in chronic hypoxia-induced pulmonary hypertension rats via regulating Akt-GSK3β-cyclin axis.
    Zhang X, Yang Z, Su S, Nan X, Xie X, Li Z, Lu D.
    Toxicol Appl Pharmacol; 2023 May 01; 466():116478. PubMed ID: 36940862
    [Abstract] [Full Text] [Related]

  • 8. HIF2α-arginase axis is essential for the development of pulmonary hypertension.
    Cowburn AS, Crosby A, Macias D, Branco C, Colaço RD, Southwood M, Toshner M, Crotty Alexander LE, Morrell NW, Chilvers ER, Johnson RS.
    Proc Natl Acad Sci U S A; 2016 Aug 02; 113(31):8801-6. PubMed ID: 27432976
    [Abstract] [Full Text] [Related]

  • 9. Quaternary ammonium salt of U50,488H elicits protective effects against hypoxic pulmonary hypertension.
    Zhou Y, Tian X, Wang X, Wang Y, Fan R, Wang Y, Feng N, Zhang S, Guo H, Gu X, Jia M, Yin W, Hou Z, Li J, Pei J.
    Eur J Pharmacol; 2018 Aug 05; 832():129-137. PubMed ID: 29782857
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Κ-opioid receptor stimulation improves endothelial function in hypoxic pulmonary hypertension.
    Wu Q, Wang HY, Li J, Zhou P, Wang QL, Zhao L, Fan R, Wang YM, Xu XZ, Yi DH, Yu SQ, Pei JM.
    PLoS One; 2013 Aug 05; 8(5):e60850. PubMed ID: 23667430
    [Abstract] [Full Text] [Related]

  • 13. miR‑371b‑5p inhibits endothelial cell apoptosis in monocrotaline‑induced pulmonary arterial hypertension via PTEN/PI3K/Akt signaling pathways.
    Zhu G, Zhang W, Liu Y, Wang S.
    Mol Med Rep; 2018 Dec 05; 18(6):5489-5501. PubMed ID: 30387816
    [Abstract] [Full Text] [Related]

  • 14. Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway.
    Li H, Lu W, Cai WW, Wang PJ, Zhang N, Yu CP, Wang DL, Liu BC, Sun W.
    Pulm Pharmacol Ther; 2014 Jun 05; 28(1):17-24. PubMed ID: 24269521
    [Abstract] [Full Text] [Related]

  • 15. C1q/TNF-related protein-9 ameliorates hypoxia-induced pulmonary hypertension by regulating secretion of endothelin-1 and nitric oxide mediated by AMPK in rats.
    Jin Q, Su H, Yang R, Tan Y, Li B, Yi W, Dong Q, Zhang H, Xing W, Sun X.
    Sci Rep; 2021 May 31; 11(1):11372. PubMed ID: 34059748
    [Abstract] [Full Text] [Related]

  • 16. Punicalagin Prevents Hypoxic Pulmonary Hypertension via Anti-Oxidant Effects in Rats.
    Shao J, Wang P, Liu A, Du X, Bai J, Chen M.
    Am J Chin Med; 2016 May 31; 44(4):785-801. PubMed ID: 27222062
    [Abstract] [Full Text] [Related]

  • 17. [Effect of 2-phenylethyl-beta-glucopyranoside isolated from Huaizhong No. 1 Rehmannia glutinosa on hypoxic pulmonary hypertension by regulating PI3K/Akt/m TOR/HIF-1α pathway].
    Zeng MN, Zhang YH, Guo PL, Zhang ZY, Liu YL, Wang R, Tie QM, Wang YY, Chang FZ, Feng WS, Zheng XK.
    Zhongguo Zhong Yao Za Zhi; 2024 Jul 31; 49(14):3857-3867. PubMed ID: 39099359
    [Abstract] [Full Text] [Related]

  • 18. Genistein attenuates hypoxic pulmonary hypertension via enhanced nitric oxide signaling and the erythropoietin system.
    Kuriyama S, Morio Y, Toba M, Nagaoka T, Takahashi F, Iwakami S, Seyama K, Takahashi K.
    Am J Physiol Lung Cell Mol Physiol; 2014 Jun 01; 306(11):L996-L1005. PubMed ID: 24705719
    [Abstract] [Full Text] [Related]

  • 19. Promoting effect of baicalin on nitric oxide production in CMECs via activating the PI3K-AKT-eNOS pathway attenuates myocardial ischemia-reperfusion injury.
    Bai J, Wang Q, Qi J, Yu H, Wang C, Wang X, Ren Y, Yang F.
    Phytomedicine; 2019 Oct 01; 63():153035. PubMed ID: 31377586
    [Abstract] [Full Text] [Related]

  • 20. Effects of astragalus polysaccharide on apoptosis of myocardial microvascular endothelial cells in rats undergoing hypoxia/reoxygenation by mediation of the PI3K/Akt/eNOS signaling pathway.
    Zhou Q, Meng G, Teng F, Sun Q, Zhang Y.
    J Cell Biochem; 2018 Jan 01; 119(1):806-816. PubMed ID: 28657671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.